A Health Economic Evaluation Framework And Bespoke Analysis For AMR Diagnostic Technologies
What the buyer wrote
PACE (Pathways to Antimicrobial Clinical Efficacy) is a £30 million initiative supporting and funding early-stage innovation in medicines and diagnostics, aimed at tackling AMR. It was established in September 2023 and is a collaboration between Innovate UK (IUK), LifeArc, and Medicines Discovery Catapult (MDC) - three leaders in the UK's health innovation and research community. The PACE programme is looking for an external provider to deliver an 'Enabling Project' in partnership related to early health economic analysis to support our cohort of AMR diagnostic innovation developers from our 2nd PACE funding call. Please see (https://paceamr.org.uk/news/ukhsa-announced-as-first-pace-collabor…
Details
- What the buyer calls it
- A Health Economic Evaluation Framework And Bespoke Analysis For AMR Diagnostic Technologies
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
Who the buyer named
Ms Laura Hough was the named contact on this notice. Questions closed on 26 Nov 2025, 16:00 GMT.